Por: RTTNews Health December 15, 2022
Biopharmaceutical company Reviva Pharmaceuticals Holdings, Inc. () announced Thursday positive data from its recently completed clinical drug-drug interaction (DDI) study investigating the potential effect of CYP3A4 enzyme on brilaroxazine in healthy subjects.The CYP3A4 enzyme plays a pivotal role in helping the body metabolize and remove small foreign molecules and is primarily found in the liver and intestine.DDI evaluation is a critical... + full article
Forbes USA Business November 29, 2022
A No-till corn fieldgetty Most of the corn grown in the US has been improved using biotechnology to provide protection from insect damage and/or herbicide tolerance. The insect resistance trait has the additional benefit of reducing mycotoxin contamination of the grain, and... + más
Serendipity: From Iconic ‘50s Restaurant To Selena Gomez Brand | Forbes
More women than men suffer strokes, but many don’t realize risk | Portland Press Herald
The Boston Globe USA Business November 15, 2022
A Boston biotech founded by researchers at the Broad Institute of MIT and Harvard has landed $157 million for its big plans to develop pills for cancer, immune conditions, neurological diseases, and a rare metabolic disorder.Jnana Therapeutics announced Tuesday that it raised a... + más
Ganni Ventures Into Beauty For The First Time With Sustainable Glitter Launch | Forbes
LabCentral opens its biggest site yet in the heart of Kendall Square | The Boston Globe
The New York Times USA Health November 10, 2022
For the first time, doctors have successfully treated a fetus by infusing a crucial enzyme into its minuscule umbilical cord, halting an otherwise fatal inherited disorder known as severe infantile Pompe disease.The baby, Ayla Bashir, now 16 months old, is developing normally,... + más
In a first, doctors treat fatal genetic disease before birth | Portland Press Herald
In a first, doctors treat fatal genetic disease before birth | WPLG Local 10
The Boston Globe USA Business November 06, 2022
Scientists from Duke, MIT, and Stanford have independently devised a molecular trick that could help make genetic therapies safer and more effective. The technology, which was disclosed in three separate papers published recently, could help ensure that treatments based on DNA... + más
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
Sally Kornbluth named next MIT president | The Boston Globe
RTTNews USA Health October 26, 2022
Aurobindo Pharma USA, Inc., affiliated to Indian pharma major Aurobindo Pharma Limited, is recalling two lots of Quinapril and Hydrochlorothiazide tablets due to the presence of Nnitroso-quinapril, a probable human carcinogen, the U.S. Food and Drug Administration said.... + más
Now you can touch Alexa on Fire tablets, too | The Verge
Council Post: How Social Media Analytics Is Transforming Pharma Decision Making | Forbes
Forbes USA Life October 08, 2022
What's in your weed? A Centers for Disease Control and Prevention (CDC) Morbidity and Mortality ... [+] Weekly Report (MMWR) report published on Friday described a tragic tale of rat poison ending up in synthetic cannabinoid products in Florida. (Photo: Getty) getty... + más
Florida tokers inadvertently smoked rat poison; 52 sickened, 4 dead | Ars Technica
NYC rat sightings up 74% from same point in 2020 despite mitigation efforts | New York Daily News
Forbes USA Business September 30, 2022
, VP and Business Leader, Infovision Social—the Research, Digital Experience, Social Media Analytics arm of InfoVision. getty Social media has opened up a whole new dimension of insights for pharma companies. The conversations happening in social media are real-world... + más
Council Post: 10 Areas To Dedicate The Bulk Of Your Social Media Budget To (And Why) | Forbes
Cadence Brings Big Data And AI Analytics To SoC Verification | Forbes
About iurex | Privacy Policy | Disclaimer |